Harris Williams Advises Altasciences on its Pending Sale to Novo Holdings A/S
February 23 2021 - 8:52AM
Business Wire
Harris Williams, a global investment bank specializing in
M&A advisory services, announces it is the lead advisor to
Altasciences, a portfolio company of Audax Private Equity, on its
pending sale to Novo Holdings A/S (Novo Holdings). Founded in 1992,
Altasciences is a fully integrated, early drug development services
platform, providing the pharma and biotech industries with a
trusted partner for drug development, from preclinical safety
testing through to clinical proof-of-concept studies. The
transaction is being led by Paul Hepper, Geoffrey Smith, Tyler
Bradshaw, Miles Annin and Bill Whitaker of the Harris Williams
Healthcare & Life Sciences (HCLS) Group and Daniel Wang, a
managing director leading the firm’s efforts in Asia.
“Altasciences’ full-service, integrated offering is uniquely
tailored to the demand of small and medium-sized biopharma
sponsors, which are expected to account for an increasing share of
the growing pipeline of drugs in development,” said Paul Hepper, a
managing director at Harris Williams. “It was a pleasure working
with the teams at Altasciences and Audax Private Equity on this
transaction and we believe the company has found a fantastic new
partner in Novo Holdings.”
Altasciences is a forward-thinking, mid-size contract research
organization offering pharmaceutical and biotechnology companies a
flexible approach to preclinical and clinical pharmacology studies,
including formulation, manufacturing and analytical services. For
over 25 years, Altasciences has been partnering with sponsors to
help support educated, faster and more complete early drug
development decisions. Altasciences’ integrated, full-service
solutions include preclinical safety testing, clinical pharmacology
and proof of concept, bioanalysis, program management, medical
writing, and biostatistics, all customizable to specific sponsor
requirements. Altasciences helps sponsors get drugs to the people
who need them, faster.
Audax Group is a leading alternative investment manager with
offices in Boston, New York and San Francisco. Since its founding
in 1999, the firm has raised over $27 billion in capital across its
private equity and private debt businesses. Audax Private Equity
has invested over $6 billion in more than 135 platforms and over
925 add-on companies, and is currently investing out of its $3.5
billion, sixth private equity fund. Through its disciplined Buy
& Build approach, Audax Group seeks to help platform companies
execute add-on acquisitions that fuel revenue growth, optimize
operations and significantly increase equity value. With more than
250 employees and over 100 investment professionals, the firm is a
leading capital partner for North American middle market
companies.
Novo Holdings is recognized as a world-leading life sciences
investor with a focus on creating long-term value. As a life
sciences investor, Novo Holdings provides seed and venture capital
to development-stage companies and takes significant ownership
positions in growth and well-established companies. Novo Holdings
also manages a broad portfolio of diversified financial assets.
Harris Williams, an investment bank specializing in M&A
advisory services, advocates for sellers and buyers of companies
worldwide through critical milestones and provides thoughtful
advice during the lives of their businesses. By collaborating as
one firm across industry groups and geographies, the firm helps its
clients achieve outcomes that support their objectives and
strategically create value. Harris Williams is committed to
execution excellence and to building enduring, valued relationships
that are based on mutual trust. Harris Williams is a subsidiary of
the PNC Financial Services Group, Inc. (NYSE: PNC).
The Harris Williams HCLS Group has experience across a broad
range of sectors, including healthcare providers; payors and payor
services; outsourced pharmaceutical services; medical device supply
chain; healthcare IT; and pharmacy. For more information on the
HCLS Group and other recent transactions, visit the HCLS Group’s
section of the Harris Williams website.
Harris Williams LLC is a registered broker-dealer and member of
FINRA and SIPC. Harris Williams & Co. Ltd is a private limited
company incorporated under English law with its registered office
at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered
with the Registrar of Companies for England and Wales (registration
number 07078852). Harris Williams & Co. Ltd is authorized and
regulated by the Financial Conduct Authority. Harris Williams &
Co. Corporate Finance Advisors GmbH is registered in the commercial
register of the local court of Frankfurt am Main, Germany, under
HRB 107540. The registered address is Bockenheimer Landstrasse
33-35, 60325 Frankfurt am Main, Germany (email address:
hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery
H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a
trade name under which Harris Williams LLC, Harris Williams &
Co. Ltd and Harris Williams & Co. Corporate Finance Advisors
GmbH conduct business.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210223005721/en/
For media inquiries, please contact Julia Moore at
media@harriswilliams.com.
PNC Financial Services (NYSE:PNC)
Historical Stock Chart
From Sep 2024 to Oct 2024
PNC Financial Services (NYSE:PNC)
Historical Stock Chart
From Oct 2023 to Oct 2024